Broad track record of ~20 years in global infectious diseases spanning product development (small molecules, monoclonal antibodies, and viral vector vaccines), health policy, program implementation, and investments. Therapeutic area expertise includes pathogens of pandemic potential (e.g. influenza, coronaviruses), HIV, TB, malaria, rabies and enteric pathogens.Career palette encompasses:• Leading R&D programs through INDs/CTAs, stringent regulatory approval and policy recommendations,• Designing and executing preclinical studies, Phase 1-4 clinical trials, and operational research studies,• Raising >300M USD in non-dilutive/public sector financing (grants and equity investments),• Creating partnerships (R&D collaborations, in-licensing/out-licensing relationships, and procurement contracts) with governments, academic institutions, private sector actors, and global health/public health organizations,• Implementing large-scale disease control programs,• Managing global, cross-functional teams, and• Publishing in top-tier scientific journals.